期刊文献+

基于通用质粒标准品的实时荧光定量PCR检测组织因子剪接异构体F3tv1及F3tv2 被引量:1

Quantitative determination of human tissue factor spliced variants F3tv1 and F3tv2 by real-time PCR with universal plasmid standard
下载PDF
导出
摘要 目的建立基于通用质粒标准品的实时荧光定量PCR(qPCR)法检测人组织因子(TF)两种剪接异构体(F3tv1和F3tv2)。方法设计基因特异性上游引物与通用下游引物,通过引物末端延伸法将2种扩增产物进行序列简并,用于构建通用质粒标准品。用qPCR法检测人白血病细胞株THP-1、Jurkat及外周血单核细胞中F3tv1与F3tv2的表达,分析该法的线性范围与特异性。结果所建qPCR方法对F3tv1与F3tv2扩增特异,线性范围均为108~101copies/μL。THP-1与外周血单核细胞中F3tv1相对表达量分别为(5.70×10-4)±(2.62×10-5)与(1.79×10-4)±(4.37×10-5);F3tv2分别为(4.94×10-5)±(2.19×10-6)与(2.98±2.18)×10-6,Jurkat细胞株F3tv1与F3tv2均未检出。结论建立的qPCR方法可对TF两种剪接异构体同时进行精确、定量地检测,为深入研究TF的选择性剪接调控机制提供实验依据。 Objective To establish a real-time PCR with universal plasmid standard for quantitative determination of human full-length and alternative spliced tissue factor transcripts F3tvl, F3tv2. Methods The gene-specific forward primers and universal reverse primer were designed. The degeneracy of the sequences aligned from amplicons of F3tvl and F3tv2 was performed by terminal primer-extension method to construct the universal plasmid standard. The expressions of F3tvl and F3tv2 in human peripheral blood monocytes and leukemia cell line THP-1 and Jurkat were validated by conceived qPCR, and the sensibility and expanded linear range were analyzed. Results F3tvl and F3tv2 were amplied specifically using the developed qPCR assay with linearity range of 101 to l0s copies per microlitre. The relative expression of F'3tvl and was [ (5.70 × 10^-4 ) . (2.62 × 10^-5 ) ] in THP-1 cells and [ ( 1.79 × 10^-4 ) ± (4.37× 10^ - 5 ) ] in peripheral blood monocytes, while F3 tv2 were [ ( 4.94 × 10^ - 5 ) ±( 2.19 × 10^ - 6 ) ] and [ ( 2.98± 2.18 ) × 10^ - 6 ] respectively. As negative control, no expression of both F3tvl and F3tv2 was detectable in Jurkat cells. Conclusion Human tissue factor spliced variants were specifically and sensitively quantified by using the established qPCR with universal plasmid standard. The method should be useful for providing experimental evidences in the study on ahernative splicing regulation of tissue factor.
出处 《临床检验杂志》 CAS CSCD 北大核心 2012年第7期485-488,共4页 Chinese Journal of Clinical Laboratory Science
基金 国家自然科学基金(30971301) 江苏省研究生创新计划(CXLX11_0606)
关键词 组织因子 选择性剪接 引物末端延伸 实时荧光定量PCR tissue factor alternative splicing terminal primer-extension real-time polymerase chain reaction
  • 相关文献

参考文献10

  • 1Giesen PL, Ranch U, Bohrmann B, et al. Blood-borne tissue factor: another view of thrombosis[J]. Proc Natl Acad Sci USA, 1999,96 (5) :2311-2315.
  • 2Bogdanov VY, Balasubramanian V, Hathcock J, et al. Alternatively spliced human tissue factor: a circulating, soluble, thrombogenic protein[J]. Nat Med,2003,9(4) :458-462.
  • 3Hobbs JE, Zakarija A, Cundiff DL, et al. Alternatively spliced hu- man tissue factor promotes tumor growth and angiogencsis in a pan- creatic cancer tumor model [ J ]. Thromb Res, 2007,120 (Suppl 2 ) : S13-S21.
  • 4van den Berg YW, van den Hengel LG, Myers HR, et al. Alterna- tively spliced tissue factor induces angiogenesis through integrin liga- tion[ J]. Proc Natl Acad Sci USA ,2009,106 (46) : 19497-19502.
  • 5Szotowski B, Goldin-Lang P, Antoniak S, et al. Alterations in myo- cardial tissue factor expression and cellular localization in dilated car- diomyopathy[ J]. J Am Coll Cardiol,2005,45(7) :1081-1089.
  • 6朱江,陈陆俊,罗光华,牟琴峰,郑璐,徐宁.实时荧光定量PCR检测人组织因子及其剪切体方法的构建[J].江苏医药,2011,37(13):1507-1510. 被引量:2
  • 7Tardos JG, Eisenreich A, Deikus G, et al. SR proteins ASF/SF2 and SRp55 participate in tissue factor biosynthesis in human mono- cytic cells[ J]. J Thromb Haemost,2008,6(5 ) :877-884.
  • 8方怡,蔡佳翌,钟济华,钟华,王海嵘,陈芳源.异常剪接组织因子在急性髓系白血病细胞株中的表达研究[J].中国实验血液学杂志,2011,19(2):288-292. 被引量:3
  • 9Mackman N. Regulation of the tissue factor gene[ J]. FASEB J, 1995,9(10) :883-889.
  • 10van den Berg YW, Versteeg HH. Alternatively spliced tissue fac- tor. A crippled protein in coagulation or a key player in non-haemo- static processes.? [J]. Hamostaseologie,2010,30 (3) : 144-149.

二级参考文献25

  • 1Nadir Y, Katz T, Sarig G, et al. Hemostatic balance on the surface of leukemic cells: the role of tissue factor and urokinase plasminogen activator receptor. Haematologica, 2005; 90 ( 11 ) : 1549 - 1556.
  • 2Bogdanov VY, Balasubramanian V, Hathcock J, et al. Alternatively spliced human tissue factor: a circulating, soluble, thrombogenic protein. Nat Med,2003 ;9(4 ) :458 -462.
  • 3Zhu J, Guo WM, Yao YY, et aL Tissue factors on acute promyelocytic leukemia and endothelial cells are differently regulated by retinoic acid, arsenic trioxide and chemotherapeutic agents. Leukemia, 1999 ; 13 (7) : 1062 - 1070.
  • 4Poitevin S, Cochery-Nouvellon E, Dupont A, et al. Monocyte/L- 10 produced in response to lipopolysaccharide modulates thrombin generation by inhibiting tissue factor expression and release of active tissue factor-bound microparticles. Thromb Haemost,2007 ;97(4) : 598 - 607.
  • 5Szotowski B, Antoniak S, Poller W, et al. Procoagulant soluble tissue factor is released from endothelial cells in response to inflammatory cytokines. Circ Res,2005,96(12) :1233 -1239.
  • 6Censarek P, Bobbe A, Grandoch M, et al. Altemativly spliced human tissue factor (asHTF) is not procoagulant. Thromb Haemost,2007 ; 97 ( 1 ) : 11 - 14.
  • 7Hobbs JE, Zakarija A, Cundiff DL, et al. Altemativly spliced human tissue factor promotes tumor growth and anguigenesis in a pancreatic cancer tumor model. Thromb Res, 2007 ;120 ( Suppl 2) : S13 -21.
  • 8Signaevsky M, Hobbs J, Doll J, et al. Role of altemativly spliced human tissue factor in pancreatic cancer growth and angiogenesis. Semin Thromb Hemost,2008;34(2) :161 - 169.
  • 9Yu JL, Rak JW. Shedding of tissue factor (TF)-containing microparticles rather than alternatively spliced TF is the main source of TF activity released from human cancer cells. J Thromb Haemost ,2004 ;2 ( 11 ) : 2065 - 2067.
  • 10Tesselaar ME, Romijn FP, Van Der Linden IK, et al. Microparticle-associated tissue factor activity: a link between cancer and thrombosis. J Thromb Haemost, 2007 ;5 ( 3 ) : 520 - 527.

共引文献3

同被引文献12

  • 1Tang X, Zheng D, Hu P, et al. Glycogen synthase kinase 3 beta in- hibits microRNA-183-96-182 cluster via the --catenin/TCF/l,EF-Ipathway in gastric cancer cells [ J ]. Nucleic Acids Res, 2013, [ Epub ahead of print J.
  • 2Gavilrn E, Srnchez-Aguayo I, Daza P, et al. GSK-313 signaling deter- mines autophagy activation in the breast tumor cell line MCF7 and inclu- sion formation in the non-tumor cell line MCF10A in response to protea- some inhibition[J]. Cell Death & Disease, 2013, 4(4) : e572.
  • 3Jamieson CH, Ailles LE, Dylla S J, et al. Granuloeyte-macrophage progenitors as candidate leukemic stem ceils in blast-crisis CML [ J]. N Engl J Med, 2004, 351(7) : 657-667.
  • 4Abrahamsson AE, Geron I, Gotlib J, et al. Glyeogen synthase ki- nase 3beta missplieing contributes to leukemia stem cell generation [J]. Proc Natl Acad Sci USA, 2009, 106(10) :3925-3929.
  • 5Wang ET, Sandberg R, Luo S, et al. Alternative isoform regulation in human tissue transcriptomes [ J ]. Nature, 2008, 456 (7221) : 470-476.
  • 6David C J, Chen M, Assanah M, et al. HnRNP proteins controlled by c-Myc deregulate pyruvate kinase mRNA splicing in cancer [ J ]. Nature, 2010,463(7279) : 364-368.
  • 7Brosseau JP, Lucier JF, Nwilati H, et al. Tumor microenvironment- associated modifications of alternative splicing [ J ]. RNA, 2014,20 (2) :189-201.
  • 8Pal S, Gupta R, Davulufi RV. Alternative transcription and altemative splicing in cancer[ J 3. Pharmacol Ther, 2012,136(3) :283-294.
  • 9Bonomi S, Gallo S, Catino M, et al. Oncogenic alternative splicing switches: role in cancer progression and prospects for therapy [ J ]. Int J Cell Biol, 2013,2013:962038.
  • 10Vargas IM, Vivas-Mejla PE. Assessment of mRNA splice variants by qRT-PCR[J]. Methods Mol Biol, 2013,1049:171-186.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部